Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Rita Carlotta Santoro"'
Autor:
Augusto B. Federici MD, Rita Carlotta Santoro MD, Cristina Santoro MD, Lisa Pieri MD, Roberto Mario Santi MD, Giovanni Barillari MD, Alessandra Borchiellini MD, Alberto Tosetto MD, Ezio Zanon MD, Raimondo De Cristofaro MD, Esther Mairal MD, Roser Mir PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Plasma-derived von Willebrand factor-containing factor VIII concentrates (pd-VWF/FVIII-C) are the mainstay of treatment in von Willebrand disease (VWD). Real-world data on efficacy and safety of these pd-VWF/FVIII-C are required. To retrospectively e
Externí odkaz:
https://doaj.org/article/4afed7a9b43643528a9fed511a516d6e
Autor:
Mario Schiavoni, CARLO PRUNETI, SARA GUIDOTTI, ALESSANDRA MOSCATELLO, FRANCESCA GIORDANO, ANTONELLA COLUCCIA, RITA CARLOTTA SANTORO, MARIA FRANCESCA MANSUETO, EZIO ZANON, RENATO MARINO, ISABELLA CANTORI, RAIMONDO DE CRISTOFARO
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Background: The health-related quality of life (HRQoL) of people with hemophilia (PWH) is an important issue, especially considering people suffering from chronic diseases beyond hemophilia. The principal aim of this study was to investigate the pres
Externí odkaz:
https://doaj.org/article/cca33725b0ef44bba1ab655be716aa53
Publikováno v:
Medicina, Vol 59, Iss 6, p 1169 (2023)
Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice. How the detection of prolonged activated aPTT with a normal prothrombin time is i
Externí odkaz:
https://doaj.org/article/7c9805e1eaff4234987448d54c96fefc
Autor:
Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 1, Iss 2 (2022)
Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (VITT). This phenomenon mimics heparin-induced thrombocytopenia, yet it does not require heparin as a trigger. This case report highlights the potential
Externí odkaz:
https://doaj.org/article/8b7321d08d4d4f3e8584a0bd18571035
Autor:
Cristina Novembrino, Ilaria Quaglia, Angelo Claudio Molinari, Alessandra Borchiellini, Antonio Coppola, Rita Carlotta Santoro, Massimo Boscolo-Anzoletti, Eleonora Galbiati, Ezio Zanon, Alessandra Valpreda
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1999 (2022)
Recombinant porcine factor VIII (rpFVIII) is indicated for treating bleeding episodes in acquired haemophilia A, but there are few data regarding laboratory methods to adequately monitor treatment. This study involving three Italian laboratories aime
Externí odkaz:
https://doaj.org/article/401372c1250a4cd58e8557ebcf86b25a
Autor:
Annarita Tagliaferri, Angelo Claudio Molinari, Flora Peyvandi, Antonio Coppola, Francesco Demartis, Chiara Biasoli, Alessandra Borchiellini, Dorina Cultrera, Raimondo De Cristofaro, Filomena Daniele, Paola Giordano, Emanuela Marchesini, Maurizio Margaglione, Renato Marino, Berardino Pollio, Paolo Radossi, Cristina Santoro, Rita Carlotta Santoro, Sergio Siragusa, Gianluca Sottilotta, Alberto Tosetto, Lydia Piscitelli, Maria Rosaria Villa, Ezio Zanon, Adele Finardi, Irene Schiavetti, Daniella Vaccari, Giancarlo Castaman
Publikováno v:
Haemophilia. 29:135-144
Introduction: Factor IX replacement therapy is used for treatment and prophylaxis of bleeding in haemophilia B. rIX-FP is an extended half-life albumin-fusion protein, which, in clinical studies, has demonstrated prolonged dosing intervals up to 21 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87da219a054020001d456401727a99bf
https://doi.org/10.1111/hae.14689
https://doi.org/10.1111/hae.14689
Autor:
Giancarlo Castaman, Christian Carulli, Raimondo De Cristofaro, Marco Follino, Angelo Lupi, Maria Elisa Mancuso, Maria Francesca Mansueto, Angelo Claudio Molinari, Pietro Pasquetti, Cristina Santoro, Rita Carlotta Santoro, Sergio Siragusa, Luigi Piero Solimeno, Armando Tripodi, Ezio Zanon, Giovanni Di Minno
IntroductionCurrent treatment for haemophilia A involves factor VIII replacement or non-replacement (emicizumab) therapies, neither of which permanently normalise factor VIII levels. Gene therapy using adeno-associated viral (AAV) vectors is an emerg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be14c744b25aa404dfcb38a163b09a3d
https://hdl.handle.net/10447/584157
https://hdl.handle.net/10447/584157
Autor:
Paolo Angelo Cortesi, Giovanni Di Minno, Ezio Zanon, Gaetano Giuffrida, Rita Carlotta Santoro, Renato Marino, Lucia Sara D’Angiolella, Ippazio Cosimo Antonazzo, Ginevra Squassabia, Francesco Clemente, Danilo Di Laura, Ernesto Cimino, Samantha Pasca, Daniela Nicolosi, Lorenzo Giovanni Mantovani
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 12; Pages: 3434
(1) Background: new generations of rFVIII products offered the possibility to improve personalized therapeutic approaches, reducing the number of infusions or increasing the protection against bleeding risk. The aim of this study was to assess the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d432c0fee9b4576088b7109de52e074
https://pubmed.ncbi.nlm.nih.gov/35743504
https://pubmed.ncbi.nlm.nih.gov/35743504
Autor:
Antonio Coppola, Massimo Franchini, Giovanni Pappagallo, Alessandra Borchiellini, Raimondo De Cristofaro, Angelo Claudio Molinari, Rita Carlotta Santoro, Cristina Santoro, Annarita Tagliaferri
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 801
Journal of Clinical Medicine, Vol 11, Iss 801, p 801 (2022)
Journal of Clinical Medicine, Vol 11, Iss 801, p 801 (2022)
Background. Regular treatment to prevent bleeding and consequent joint deterioration (prophylaxis) is the standard of care for persons with severe hemophilia A, traditionally based on intravenous infusions of the deficient clotting FVIII concentrates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef23804bc2de4e1fe4e55ef479ba03ac
Autor:
Mario Schiavoni, CARLO PRUNETI, SARA GUIDOTTI, ALESSANDRA MOSCATELLO, FRANCESCA GIORDANO, ANTONELLA COLUCCIA, RITA CARLOTTA SANTORO, MARIA FRANCESCA MANSUETO, EZIO ZANON, RENATO MARINO, ISABELLA CANTORI, RAIMONDO DE CRISTOFARO
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases. 15:e2023005
Background: The health-related quality of life (HRQoL) of people with hemophilia (PWH) is an important issue, especially considering people suffering from chronic diseases beyond hemophilia. The principal aim of this study was to investigate the pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67692a15385015d89a082c206d13105a
https://doi.org/10.4084/mjhid.2023.005
https://doi.org/10.4084/mjhid.2023.005